BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 3389573)

  • 1. Systemic reactions during maintenance immunotherapy with honey bee venom.
    Bousquet J; Ménardo JL; Velasquez G; Michel FB
    Ann Allergy; 1988 Jul; 61(1):63-8. PubMed ID: 3389573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of Hymenoptera venom allergy in Eastern Spain.
    Fernandez J; Soriano V; Mayorga L; Mayor M
    Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
    Díez Gómez ML; Quirce Gancedo S; Juliá de Páramo B
    Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological and clinical study on bee venom allergy among beekeepers].
    Pastorello EA; Incorvaia C; Sarassi A; Qualizza R; Bigi A; Farioli L
    Boll Ist Sieroter Milan; 1988; 67(5-6):386-92. PubMed ID: 3154984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
    Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
    Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypersensitivity to honey bee venom].
    Adamek-Guzik T
    Przegl Lek; 1994; 51(4):161-6. PubMed ID: 8058985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Accelerated desensitization for hymenoptera venom allergy in 30 hours: efficacy and safety in 150 cases].
    van der Brempt X; Ledent C; Mairesse M
    Rev Med Brux; 1997 Jun; 18(3):120-4. PubMed ID: 9273600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylaxis after Hymenoptera sting without detectable specific IgE.
    Zidarn M; Kosnik M; Drinovec I
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Mar; 16(1):31-3. PubMed ID: 17992452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of IgG and IgE antibody levels to honey bee venom allergens with protection to sting challenge.
    Hoffman DR; Gillman SA; Cummins LH; Kozak PP; Oswald A
    Ann Allergy; 1981 Jan; 46(1):17-23. PubMed ID: 6257151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term IgG4 determinations in hymenoptera-sensitive treated patients.
    Gentlesk MJ; Halpern GM; Mansmann HC
    Ann Allergy; 1987 Oct; 59(4):267-72. PubMed ID: 3662129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A; Confino-Cohen R
    J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI; Eng PA
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology.
    Bousquet J; Müller UR; Dreborg S; Jarisch R; Malling HJ; Mosbech H; Urbanek R; Youlten L
    Allergy; 1987 Aug; 42(6):401-13. PubMed ID: 3310714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of rush immunotherapy (RIT) on Hymenoptera allergy].
    Hirata H; Yukawa T; Arima M; Yamada G; Makino S; Fukuda T
    Arerugi; 1999 Dec; 48(12):1331-6. PubMed ID: 10666921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honey bee venom allergy immunological studies of systemic and large local reactions.
    Hoffman DR
    Ann Allergy; 1978 Nov; 41(5):278-82. PubMed ID: 717848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.